Sage Journals: Discover world-class research

Free access

Review article

First published 2014-3

Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases

Khuder Alagha, Alain Palot, Tunde Sofalvi [...]

Sage Open Chronic Disease

Open access

Research article

First published 2020

Efficacy and safety of revefenacin for nebulization in patients with chronic obstructive pulmonary disease taking concomitant ICS/LABA or LABA: subgroup analysis from phase III trials

Sanjay Sethi, James F. Donohue, Gary T. Ferguson [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2016-12

Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience

Christian Vogelberg

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2017-4

Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy

Kesavan Suresh Babu, Jaymin Bhagwanji Morjaria

Sage Open Chronic Disease

Open access

Review article

First published 2018

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate,umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Mario Malerba, Matteo Nardin, Giuseppe Santini [...]

Therapeutic Advances in Respiratory Disease

Free access

Review article

First published 2011-6

NVA237,a long-acting muscarinic antagonist,as an emerging therapy for chronic obstructive pulmonary disease

Claus Vogelmeier, Donald Banerji

Therapeutic Advances in Respiratory Disease

Retricted access

Other

First published 2010-3

Clozapine: Agonistic and Antagonistic Salivary Secretory Actions

J. Ekström, T. Godoy, A. Riva

Journal of Dental Research

Open access

Review article

First published 2019

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base

Anthony D. D’Urzo, Dave Singh, James F. Donohue [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2019

The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD: current evidence and future prospects

Eric Derom, Guy G. Brusselle, Guy F. Joos

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2013-7

Aclidinium Bromide: An Alternative Long-Acting Inhaled Anticholinergic in the Management of Chronic Obstructive Pulmonary Disease

J Andrew Woods, Kimberly L Nealy, Robert W Barrons

Annals of Pharmacotherapy

Search results